Antiapoptotic activity of bovine papilloma virus: Implications for the control of oncogenesis

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 927-933

  Melchinger, Wolfgang ^a   Strauss, Susanne ^a   Zucker, Birgit ^a   Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

apoptosis; BPV; oncogenesis; TGF

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PREVENTION; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

EID: 0029958749     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Weinberg RA: Oncogenes, antioncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
2. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. Newbold RF and Overell RW: Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304: 648-651, 1983.
4. Shaw JW, Wright WE and Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochem Biophys Acta 1072: 1-7, 1991.
5. Clouston WM and Kerr JFR: Apoptosis, lymphocytotoxicity and the containment of viral infections. Med Hypoth 18: 399-404, 1985.
6. Stoker MGP, Shearer M and O'Neill C: Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1: 297-310, 1966.
7. Mehta PP, Bertram JS and Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44: 187-196, 1986.
8. Martin W, Zempel G, Hülser D and Willecke K: Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Cancer Res 51: 5348-5354, 1991.
9. Jürgensmeier JM, Viesel E, Höfler P and Bauer G: TGF-β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 54: 393-398, 1994.
10. Bauer G: Resistance to TGF-β-induced elimination of transformed cells is required during tumor progression. Int J Oncol 6: 1227-1229, 1995.
11. Bauer G: (Invited Review) Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol Histopathol 11: 237-255, 1996.
12. Höfler P, Wehrle I and Bauer G: TGF-β induces an inhibitory effect of normal cells directed against transformed cells. Int J Cancer 54: 125-130, 1993.
13. Jürgensmeier JM, Höfler P and Bauer G: TGF-β-induced elimination of transformed fibroblasts by normal cells: independence of cell-to-cell contact and dependence on reactive oxygen species. Int J Oncol 5: 525-531, 1994.
14. Langer C, Jürgensmeier JM and Bauer G: Reactive oxygen species act both at TGF-β-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp Cell Res 222: 117-124, 1996.
15. Picht G, Hundertmark N, Schmitt CP and Bauer G: Clonal analysis of the effect of TGF-β on the apoptosis-inducing activity of normal cells. Exp Cell Res 218: 71-78, 1995.
16. Wehrle I, Jakob A, Höfler P and Bauer G: Transformation of murine fibroblasts by UV light and TGF-β: establishment of an autocrine TGF-β loop. Int J Oncol 5: 1341-1346, 1994.
17. Bauer G, Höfler P and Simon M: Epstein-Barr virus induction by a serum factor II. Purification of a highmolecular weight protein that is responsible for induction. J Biol Chem 257: 11405-11410, 1982.
18. Gorcyca W, Gong J and Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in-situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951, 1993.
19. Cook JA, Pass HI, Russo A, Iype S and Mitchell JB: Use of monochlorobimane for glutathione measurements in hamster and human tumor cell lines. Int J Radiat Oncol Biol Phys 16: 1321-1324, 1989.
20. Strauß SC, Weber M, Schächtele C and Bauer G: PKC-dependent and -independent cellular effects induced by recombinant transforming growth factor type beta 1. Int J Oncol 7: 565-572, 1995.
21. Pan H and Griep AE: Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Develop 9: 2157-2169, 1995.
22. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, and White E: The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89: 7742-7746, 1992.
23. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, and Rickinson A: Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 90: 8479-8483, 1993.
24. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
25. Henderson S, Rowe M, Gregory C, Croom Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1116, 1991.
26. Lowy DR, Dvoretsky I, Shober R, Law MF, Engel L and Howley PM: In vitro tumorigenic transformation by a defined subgenomic fragment of bovine papilloma virus. Nature 287: 72-74, 1980.
27. Dvoretsky I, Shober R, Chattopadhyay SK and Lowy DR: A quantitative in vitro focus assay for bovine papilloma virus. Virology 103: 369-375, 1980.
28. Campo MS and Spandidos DA: Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol 64: 549-557, 1983.
29. DiMaio D: Transforming activity of bovine and human papillomaviruses in cultured cells. Adv Cancer Res 56: 133-159, 1991.
30. Sarver N, Rabson MS, Yang YC, Byrne DR and Howley PM: Localization and analysis of bovine papillomavirus type 1 transforming functions. J Virol 52: 377-388, 1984.
31. Yang YC, Okayama H and Howley PM: Bovine papillomavirus contains multiple transforming genes. Proc Natl Acad Sci USA 82: 1030-1034, 1985.
32. Mansur CP and Androphy EJ: Cellular transformation by papillomavirus oncoproteins. Biochim Biophys Acta 1155: 323-345, 1993.
33. Schmitt J, Schlehofer JR, Mergener K, Gissmann L and zur Hausen H: Amplification of bovine papillomavirus DNA by N-methyl-N′-nitro-N-nitrosoguanidine, ultraviolet irradiation, or infection with herpes simplex virus. Virology 172: 73-81, 1989.
34. Jackson ME, Campo MS and Gaukroger JM: Cooperation between papillomaviruses and chemical cofactors in oncogenesis. Crit Rev Oncogen 4: 277-291, 1993.
35. Pennie WD and Campo S: Synergism between bovine papillomavirus type 4 and the flavenoid quercetin in cell transformation in vitro. Virology 190: 861-865, 1992.
36. Gaukroger JM, Bradley A, Chadrachud L, Jarrett WFH and Campo MS: Interaction between bovine papillomavirus type 4 and cocarcinogens in the production of malignant tumours. J Gen Virol 74: 2275-2280, 1993.
37. Campo MS, O'Neil BWO, Barron RJ and Jarrett WFH: Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 15: 1597-1601, 1994.
38. Bronner MP, Cullin C, Reed JC and Furth EE: The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Path 146: 20-26, 1995.
39. Pathmanathan R, Prasad U, Sadler R, Flynn K and Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. New Engl J Med 333: 693-698, 1995.
40. Lindeberg H and Elbrond O: Malignant tumours in patients with a history of multiple laryngeal papillomas: the significance of irradiation. Clin Otolaryngol 16: 149-151, 1991.
41. Zur Hausen H: Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics Microbiol Immunol 186: 131-156, 1994.
42. Zur Hausen H and de Villiers E-M: Human papillomaviruses. Ann Rev Microbiol 48: 427-447, 1994.
43. Havre PA, Yuan J, Hedrick L, Cho KR and Glazer PM: P53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 55: 4420-4424, 1995.
44. DiPaolo JA, Woodworth CD, Popescu NC, Notario V and Doninger J: Induction of human cervical carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4: 395-399, 1989.
45. Dürst MD, Gallahan D, Jay D and Rhim JS: Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173: 767-771, 1989.
46. Garrett LR, Perez-Reyes N, Smith PP and McDougall JK: Interaction of HPV-18 and nitrosomethyl-urea in the induction of squameous cell carcinoma. Carcinogenesis 14: 329-332, 1993.